Fibrinogen γ′ chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway

Rehana S. Lovely, Lynn K. Boshkov, Ulla M. Marzec, Stephen R. Hanson, David H. Farrell

Research output: Contribution to journalArticlepeer-review

28 Scopus citations


The minor γA/γ′ isoform of fibrinogen contains a high affinity binding site for thrombin exosite II that is lacking in the major fibrinogen isoform, γA/γA fibrinogen. The biological consequences of γ′ chain binding to thrombin were therefore investigated. Coagulation assays, thrombin activity assays, and a primate thrombosis model were used to characterize the biological effects of the γ′ 410-427 peptide. The γ′ peptide had little effect on thrombin cleavage of the small peptidyl substrate tosyl-glycyl-prolyl-arginine-4-nitranilide acetate. However, in vitro assays demonstrated that the γ′ peptide inhibited thrombin cleavage of larger proteinaceous substrates, including fibrinogen and factor VIII. The γ′ peptide inhibited the activated partial thromboplastin time in plasma and showed greater inhibition of activated partial thromboplastin time assays than prothrombin time assays, consistent with the inhibition of factor VIII cleavage. Studies in a baboon thrombosis model showed that the γ′ 410-427 peptide inhibited fibrin-rich thrombus formation (typical of venous thrombi) and, to a lesser extent, platelet-rich thrombus formation (typical of arterial thrombi). These results indicate that binding of thrombin exosite II by the γ′ peptide has selective effects on the intrinsic pathway.

Original languageEnglish
Pages (from-to)494-503
Number of pages10
JournalBritish Journal of Haematology
Issue number3
StatePublished - Nov 2007


  • Animal model
  • Anticoagulants
  • Blood coagulation
  • Factor VIII
  • Thrombin
  • Thrombosis


Dive into the research topics of 'Fibrinogen γ′ chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway'. Together they form a unique fingerprint.

Cite this